Remove en health-information
article thumbnail

Sensyne Health launches diabetes app in the UK

pharmaphorum

UK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes spectrum manage their condition. The app – called DBm-Health – can help users to monitor their blood glucose levels and send readings, notes and medication information to their healthcare practitioner to assess remotely.

article thumbnail

Humana lawsuit exposes fraud risk in high-growth telehealth market

pharmaphorum

Health insurer Humana has filed a lawsuit against telemedicine company QuivvyTech that it says resulted in fraudulent prescriptions worth millions of dollars being written for duped customers. Humana says it paid out between $590,000 and $2.3 Image by Sabine van Erp from Pixabay.

Marketing 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pilot study backs Kaia Health app for back pain relief

pharmaphorum

An app developed by Kaia Health to help people suffering from back pain who may not want to take painkillers has shown its worth again in a study conducted with a health benefit plan in the US. The post Pilot study backs Kaia Health app for back pain relief appeared first on.

article thumbnail

2021 market access prospects for Spain

pharmaphorum

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. Spain, like many European countries, have seen biosimilars as a route to helping manage pressure on health care spending. Health economics to play a greater role. Higher biosimilar savings.

article thumbnail

Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer

The Pharma Data

De laatste handelsdag van de Aandelen aan Euronext Amsterdam en Euronext Brussel (“ Euronext “) zal op 24 mei 2021 zijn en de notering van en de handel in de Aandelen zal eindigen per 25 mei 2021. Overdracht van de Aandelen en betaling van de Biedprijs zal plaatsvinden op 3 mei 2021. ING Bank N.V.

article thumbnail

Drug price negotiations: pCPA consulting on a Temporary Access Process (pTAP)

Pharma in Brief

CADTH Time-Limited Reimbursement Recommendations Starting in the fall of 2023, CADTH, which conducts health technology assessments ( HTAs ) to inform public insurers, will introduce time-limited reimbursement recommendations for certain drug products. Evidence-generation plans. Evidentiary gaps.

Drugs 40
article thumbnail

Unsure whether to get a COVID-19 jab? Just ask Vira!

pharmaphorum

Or just uncertain whether you should be vaccinated as en expectant mother, or if you can choose which vaccine you receive? “We envision developing similar chatbots to help individuals make more informed decisions about various topics such as quitting smoking, donating blood, voting and more,” they add. . Just ask Vira!